Form 4: Arteris Inc. COO Laurent R. Moll Sells Shares to Cover Tax Obligations
SEC Form 4
Laurent R. Moll, Chief Operating Officer of Arteris, Inc., sold shares of common stock on April 2nd and 4th, 2025, to cover tax liabilities related to the release of restricted stock units.
Summary
- Laurent R. Moll, the Chief Operating Officer of Arteris, Inc., reported the sale of Arteris, Inc. [AIP] common stock.
- The transactions occurred on April 2, 2025, and April 4, 2025.
- The sales were executed to satisfy the reporting person's tax liability arising from the release of restricted stock units.
- On April 2, 2025, Moll sold 1,927 shares, 891 shares, and 1,885 shares at a price of $7.1186 per share.
- On April 4, 2025, Moll sold 1,260 shares at a price of $6.15 per share.
- These transactions were made pursuant to a 10b5-1 trading plan adopted on March 15, 2024.
- Following these transactions, Moll directly owns 481,573 shares of Arteris, Inc. common stock.
Sentiment
Score: 5
Explanation: Neutral sentiment. This is a routine transaction related to tax obligations and pre-planned under a 10b5-1 trading plan. It doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
This is a routine Form 4 filing, indicating insider transactions. It's common for executives to sell shares to cover tax obligations, especially after the vesting of restricted stock units. The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on current market information.
Comparison to Industry Standards
- Executive stock sales are a common occurrence in publicly traded companies, particularly in the technology sector.
- Companies like Cadence Design Systems and Synopsys, which operate in similar markets, often see similar patterns of insider trading related to equity compensation.
- The use of 10b5-1 plans is a standard practice to avoid accusations of trading on inside information, aligning with best practices in corporate governance.
Stakeholder Impact
- The stock sales could have a minor, temporary impact on the stock price due to increased selling pressure.
- However, since the transactions were pre-planned and for tax purposes, the overall impact on shareholder value is likely to be minimal.
Key Dates
| Date | Description |
|---|---|
| 2024-03-15 | Date of adoption of the 10b5-1 trading plan. |
| 2025-04-02 | Date of first stock sale: 1,927 shares, 891 shares, and 1,885 shares at $7.1186 per share. |
| 2025-04-04 | Date of second stock sale: 1,260 shares at $6.15 per share. |
Keywords
Form 4, insider trading, stock sale, Laurent R. Moll, Arteris, Inc., AIP, COO, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.